John Kappler
Concepts (926)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
T-Lymphocytes | 239 | 2021 | 1928 | 6.550 |
Why?
| Receptors, Antigen, T-Cell | 125 | 2024 | 704 | 5.920 |
Why?
| Histocompatibility Antigens Class II | 80 | 2021 | 362 | 5.740 |
Why?
| Receptors, Antigen, T-Cell, alpha-beta | 64 | 2024 | 336 | 5.220 |
Why?
| CD4-Positive T-Lymphocytes | 55 | 2024 | 1056 | 4.280 |
Why?
| Major Histocompatibility Complex | 56 | 2024 | 230 | 3.930 |
Why?
| Thymus Gland | 59 | 2024 | 306 | 2.780 |
Why?
| Peptides | 48 | 2021 | 925 | 2.670 |
Why?
| Peptide Fragments | 24 | 2021 | 692 | 2.620 |
Why?
| Hybridomas | 74 | 2019 | 234 | 2.470 |
Why?
| Lymphocyte Activation | 81 | 2020 | 1106 | 2.220 |
Why?
| Antigens | 50 | 2021 | 355 | 2.010 |
Why?
| Mice | 331 | 2024 | 16937 | 1.950 |
Why?
| Histocompatibility Antigens | 17 | 2019 | 107 | 1.890 |
Why?
| Epitopes, T-Lymphocyte | 9 | 2021 | 186 | 1.760 |
Why?
| B-Lymphocytes | 61 | 2017 | 815 | 1.640 |
Why?
| Animals | 371 | 2024 | 35361 | 1.640 |
Why?
| H-2 Antigens | 38 | 2011 | 115 | 1.640 |
Why?
| Autoantigens | 23 | 2021 | 417 | 1.480 |
Why?
| Amino Acid Sequence | 72 | 2019 | 2058 | 1.450 |
Why?
| Autoimmunity | 13 | 2021 | 862 | 1.410 |
Why?
| Epitopes | 47 | 2021 | 470 | 1.400 |
Why?
| Berylliosis | 10 | 2021 | 185 | 1.340 |
Why?
| Molecular Sequence Data | 68 | 2015 | 2832 | 1.200 |
Why?
| Autoimmune Diseases | 7 | 2021 | 426 | 1.200 |
Why?
| Protein Binding | 36 | 2021 | 2121 | 1.200 |
Why?
| Enterotoxins | 26 | 2009 | 89 | 1.180 |
Why?
| Models, Molecular | 29 | 2018 | 1492 | 1.180 |
Why?
| Antigen Presentation | 17 | 2021 | 206 | 1.160 |
Why?
| Immune Tolerance | 31 | 2024 | 355 | 1.150 |
Why?
| Histocompatibility Antigens Class I | 12 | 2018 | 200 | 1.070 |
Why?
| Diabetes Mellitus, Type 1 | 16 | 2021 | 3628 | 1.040 |
Why?
| Immunologic Memory | 26 | 2020 | 349 | 1.030 |
Why?
| Antibodies, Monoclonal | 55 | 2020 | 1367 | 1.020 |
Why?
| Beryllium | 8 | 2021 | 152 | 1.010 |
Why?
| Baculoviridae | 9 | 2015 | 44 | 0.970 |
Why?
| Alleles | 13 | 2017 | 845 | 0.950 |
Why?
| HLA-DP beta-Chains | 10 | 2021 | 84 | 0.950 |
Why?
| Insulin | 11 | 2024 | 2326 | 0.940 |
Why?
| CD8-Positive T-Lymphocytes | 24 | 2021 | 857 | 0.940 |
Why?
| Interleukin-2 | 37 | 2015 | 436 | 0.860 |
Why?
| Superantigens | 18 | 2002 | 70 | 0.830 |
Why?
| Mice, Inbred C57BL | 102 | 2024 | 5440 | 0.810 |
Why?
| Antigens, Surface | 24 | 2011 | 151 | 0.780 |
Why?
| Mice, Transgenic | 48 | 2024 | 2119 | 0.760 |
Why?
| Cell Line | 41 | 2021 | 2781 | 0.720 |
Why?
| Cathepsins | 1 | 2021 | 24 | 0.720 |
Why?
| Lysosomes | 2 | 2021 | 138 | 0.720 |
Why?
| HLA-DR Antigens | 9 | 2016 | 224 | 0.700 |
Why?
| Protein Conformation | 21 | 2018 | 859 | 0.680 |
Why?
| Peptide Library | 6 | 2013 | 84 | 0.680 |
Why?
| T-Lymphocyte Subsets | 19 | 2013 | 412 | 0.680 |
Why?
| Adjuvants, Immunologic | 12 | 2016 | 221 | 0.680 |
Why?
| Antigens, Neoplasm | 8 | 2021 | 309 | 0.670 |
Why?
| Flow Cytometry | 28 | 2015 | 1156 | 0.640 |
Why?
| Islets of Langerhans | 4 | 2021 | 791 | 0.630 |
Why?
| Immunoglobulin G | 10 | 2017 | 847 | 0.610 |
Why?
| Genes, MHC Class II | 18 | 2014 | 73 | 0.610 |
Why?
| Base Sequence | 36 | 2016 | 2142 | 0.600 |
Why?
| Mammary Tumor Virus, Mouse | 12 | 1995 | 44 | 0.590 |
Why?
| Chromogranin A | 2 | 2015 | 42 | 0.560 |
Why?
| Amino Acids | 5 | 2022 | 485 | 0.550 |
Why?
| Binding Sites | 20 | 2021 | 1252 | 0.550 |
Why?
| Membrane Proteins | 14 | 2020 | 1119 | 0.550 |
Why?
| Mice, Inbred BALB C | 48 | 2021 | 1245 | 0.540 |
Why?
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 4 | 2012 | 26 | 0.530 |
Why?
| Mice, Inbred NOD | 11 | 2020 | 588 | 0.520 |
Why?
| Ikaros Transcription Factor | 2 | 2013 | 23 | 0.510 |
Why?
| Antigen-Presenting Cells | 21 | 2015 | 150 | 0.500 |
Why?
| Lymphocyte Cooperation | 21 | 1990 | 49 | 0.500 |
Why?
| Complementarity Determining Regions | 8 | 2012 | 49 | 0.490 |
Why?
| Proto-Oncogene Proteins | 12 | 2009 | 638 | 0.490 |
Why?
| CD3 Complex | 10 | 2018 | 103 | 0.480 |
Why?
| Immunity, Cellular | 16 | 2010 | 265 | 0.480 |
Why?
| Proto-Oncogene Proteins c-bcl-2 | 12 | 2007 | 232 | 0.480 |
Why?
| Alum Compounds | 6 | 2016 | 22 | 0.480 |
Why?
| Antibodies, Monoclonal, Murine-Derived | 1 | 2015 | 87 | 0.480 |
Why?
| Hypersensitivity | 3 | 2016 | 249 | 0.460 |
Why?
| Evolution, Molecular | 4 | 2019 | 466 | 0.460 |
Why?
| Histone Demethylases | 3 | 2020 | 31 | 0.450 |
Why?
| Antigens, Differentiation, T-Lymphocyte | 18 | 1991 | 88 | 0.450 |
Why?
| bcl-2-Associated X Protein | 4 | 2006 | 55 | 0.450 |
Why?
| Immunoglobulin Variable Region | 11 | 2012 | 79 | 0.440 |
Why?
| Gene Expression Regulation | 22 | 2015 | 2548 | 0.440 |
Why?
| Mutation | 25 | 2022 | 3717 | 0.440 |
Why?
| Thymoma | 5 | 2012 | 33 | 0.440 |
Why?
| Antibody Formation | 21 | 2010 | 290 | 0.430 |
Why?
| Mice, Inbred Strains | 36 | 2000 | 406 | 0.430 |
Why?
| Conserved Sequence | 3 | 2009 | 227 | 0.420 |
Why?
| Apoptosis | 15 | 2011 | 2503 | 0.420 |
Why?
| Spleen | 32 | 2016 | 507 | 0.420 |
Why?
| Lymphocytes, Null | 1 | 2012 | 3 | 0.410 |
Why?
| Lymphokines | 12 | 1984 | 127 | 0.410 |
Why?
| HLA-DR4 Antigen | 2 | 2005 | 78 | 0.410 |
Why?
| Bacterial Toxins | 6 | 1997 | 106 | 0.410 |
Why?
| Crystallography, X-Ray | 10 | 2018 | 436 | 0.400 |
Why?
| Antigens, Viral | 10 | 2001 | 178 | 0.400 |
Why?
| Protein Processing, Post-Translational | 8 | 2018 | 455 | 0.400 |
Why?
| Apoptosis Regulatory Proteins | 10 | 2011 | 182 | 0.390 |
Why?
| Spike Glycoprotein, Coronavirus | 3 | 2022 | 108 | 0.390 |
Why?
| Ligands | 13 | 2022 | 622 | 0.390 |
Why?
| Protein Structure, Tertiary | 10 | 2021 | 840 | 0.380 |
Why?
| Staphylococcus aureus | 12 | 1999 | 438 | 0.380 |
Why?
| Humans | 129 | 2022 | 129650 | 0.380 |
Why?
| Glycoproteins | 3 | 2011 | 338 | 0.370 |
Why?
| Cancer Vaccines | 5 | 2021 | 164 | 0.360 |
Why?
| Antigens, Bacterial | 8 | 2013 | 119 | 0.360 |
Why?
| Jumonji Domain-Containing Histone Demethylases | 3 | 2018 | 60 | 0.360 |
Why?
| Clone Cells | 22 | 2024 | 261 | 0.350 |
Why?
| Toll-Like Receptor 7 | 4 | 2016 | 38 | 0.350 |
Why?
| Carrier Proteins | 10 | 2009 | 743 | 0.350 |
Why?
| Cells, Cultured | 36 | 2021 | 4083 | 0.350 |
Why?
| Interferon-gamma | 14 | 2016 | 770 | 0.340 |
Why?
| Antibodies | 10 | 2009 | 398 | 0.340 |
Why?
| B-Lymphocyte Subsets | 4 | 2020 | 74 | 0.340 |
Why?
| Cell Differentiation | 28 | 2021 | 1902 | 0.320 |
Why?
| Proinsulin | 2 | 2021 | 52 | 0.320 |
Why?
| Signal Transduction | 17 | 2016 | 4925 | 0.310 |
Why?
| Ovalbumin | 21 | 2011 | 179 | 0.310 |
Why?
| Immunotherapy | 5 | 2021 | 592 | 0.300 |
Why?
| Nickel | 2 | 2012 | 54 | 0.300 |
Why?
| CD11c Antigen | 5 | 2020 | 41 | 0.300 |
Why?
| Cross Reactions | 10 | 2012 | 132 | 0.290 |
Why?
| Gene Expression | 11 | 2017 | 1472 | 0.290 |
Why?
| Amino Acid Motifs | 7 | 2019 | 213 | 0.290 |
Why?
| HLA-DQ Antigens | 6 | 2019 | 179 | 0.280 |
Why?
| Immunoglobulin Fab Fragments | 3 | 2006 | 59 | 0.280 |
Why?
| Cytokines | 13 | 2020 | 2017 | 0.280 |
Why?
| Arthritis, Rheumatoid | 5 | 2014 | 1092 | 0.280 |
Why?
| beta 2-Microglobulin | 4 | 2010 | 49 | 0.280 |
Why?
| Cytochrome c Group | 5 | 2002 | 42 | 0.270 |
Why?
| Insecta | 4 | 2009 | 65 | 0.260 |
Why?
| Histones | 4 | 2018 | 588 | 0.260 |
Why?
| Dendritic Cells | 7 | 2013 | 478 | 0.260 |
Why?
| Cell Proliferation | 10 | 2020 | 2391 | 0.250 |
Why?
| Kinetics | 18 | 2021 | 1642 | 0.250 |
Why?
| HLA-D Antigens | 3 | 1998 | 34 | 0.240 |
Why?
| Lupus Erythematosus, Systemic | 3 | 2017 | 247 | 0.240 |
Why?
| Cell Survival | 18 | 2009 | 1086 | 0.240 |
Why?
| Staphylococcus | 5 | 1994 | 74 | 0.230 |
Why?
| Transcription, Genetic | 8 | 2020 | 1418 | 0.230 |
Why?
| Interleukin-12 | 2 | 2016 | 118 | 0.230 |
Why?
| Protein Folding | 2 | 2021 | 266 | 0.220 |
Why?
| Herpesviridae Infections | 2 | 2017 | 141 | 0.220 |
Why?
| T-Lymphocytes, Helper-Inducer | 9 | 1989 | 135 | 0.220 |
Why?
| Macromolecular Substances | 17 | 2003 | 213 | 0.210 |
Why?
| Macrophages | 19 | 2011 | 1480 | 0.210 |
Why?
| Surface Plasmon Resonance | 5 | 2021 | 88 | 0.210 |
Why?
| Mice, Knockout | 17 | 2024 | 2871 | 0.210 |
Why?
| Positive Transcriptional Elongation Factor B | 2 | 2020 | 29 | 0.210 |
Why?
| DNA | 12 | 2016 | 1400 | 0.210 |
Why?
| T-Cell Antigen Receptor Specificity | 3 | 2011 | 51 | 0.210 |
Why?
| Germ Cells | 2 | 2016 | 59 | 0.200 |
Why?
| Antiviral Agents | 2 | 2021 | 712 | 0.200 |
Why?
| Concanavalin A | 18 | 1990 | 75 | 0.200 |
Why?
| Lung | 7 | 2021 | 3930 | 0.200 |
Why?
| Receptors, Cell Surface | 3 | 2020 | 380 | 0.200 |
Why?
| T-Box Domain Proteins | 4 | 2020 | 96 | 0.200 |
Why?
| Cell Death | 13 | 2006 | 354 | 0.200 |
Why?
| Natural Killer T-Cells | 2 | 2013 | 65 | 0.200 |
Why?
| Neoplasms | 5 | 2021 | 2470 | 0.200 |
Why?
| Enzyme-Linked Immunosorbent Assay | 10 | 2017 | 833 | 0.200 |
Why?
| Homeostasis | 5 | 2007 | 611 | 0.190 |
Why?
| Vaccines, Subunit | 3 | 2012 | 48 | 0.190 |
Why?
| Neoplasms, Experimental | 3 | 2021 | 171 | 0.190 |
Why?
| Immune System | 5 | 2013 | 175 | 0.190 |
Why?
| Oligonucleotide Array Sequence Analysis | 5 | 2008 | 769 | 0.190 |
Why?
| Transfection | 17 | 2009 | 911 | 0.190 |
Why?
| Aging | 8 | 2015 | 1776 | 0.190 |
Why?
| Recombinant Proteins | 7 | 2005 | 1304 | 0.190 |
Why?
| Structure-Activity Relationship | 10 | 2006 | 548 | 0.190 |
Why?
| Sequence Homology, Amino Acid | 6 | 2019 | 372 | 0.190 |
Why?
| Polymorphism, Genetic | 6 | 2012 | 640 | 0.190 |
Why?
| Antibodies, Monoclonal, Humanized | 3 | 2022 | 759 | 0.190 |
Why?
| Peptidyl Transferases | 1 | 2021 | 7 | 0.180 |
Why?
| Crystallization | 2 | 2015 | 138 | 0.180 |
Why?
| Chemokine CCL3 | 1 | 2021 | 17 | 0.180 |
Why?
| Saccharomyces cerevisiae | 1 | 2005 | 532 | 0.180 |
Why?
| Pancreas | 2 | 2021 | 306 | 0.180 |
Why?
| Chemokine CCL4 | 1 | 2021 | 23 | 0.180 |
Why?
| Bcl-2-Like Protein 11 | 9 | 2009 | 38 | 0.180 |
Why?
| HLA-C Antigens | 1 | 2021 | 35 | 0.180 |
Why?
| Female | 72 | 2021 | 68776 | 0.180 |
Why?
| Electrophoresis, Polyacrylamide Gel | 9 | 2011 | 330 | 0.180 |
Why?
| Cloning, Molecular | 12 | 2000 | 524 | 0.180 |
Why?
| Autoantibodies | 6 | 2017 | 1466 | 0.170 |
Why?
| Cyclin-Dependent Kinase 9 | 1 | 2020 | 10 | 0.170 |
Why?
| Epitope Mapping | 4 | 2015 | 57 | 0.170 |
Why?
| Immunoglobulin Idiotypes | 6 | 1986 | 27 | 0.170 |
Why?
| Inflammation | 5 | 2020 | 2736 | 0.170 |
Why?
| Synovial Fluid | 2 | 2000 | 66 | 0.170 |
Why?
| RNA Polymerase II | 2 | 2020 | 317 | 0.170 |
Why?
| HLA-DP Antigens | 2 | 2010 | 32 | 0.170 |
Why?
| Substrate Specificity | 3 | 2017 | 368 | 0.170 |
Why?
| Hemolytic Plaque Technique | 16 | 1983 | 28 | 0.170 |
Why?
| Nerve Growth Factors | 1 | 2000 | 75 | 0.170 |
Why?
| Haptens | 4 | 1988 | 20 | 0.170 |
Why?
| Bronchoalveolar Lavage Fluid | 2 | 2020 | 644 | 0.170 |
Why?
| Animal Fur | 1 | 2019 | 1 | 0.170 |
Why?
| Glycosaminoglycans | 1 | 2000 | 84 | 0.160 |
Why?
| Genes | 15 | 1990 | 226 | 0.160 |
Why?
| Membrane Glycoproteins | 6 | 2013 | 474 | 0.160 |
Why?
| CD8 Antigens | 9 | 2006 | 76 | 0.160 |
Why?
| Alveolitis, Extrinsic Allergic | 1 | 2020 | 98 | 0.160 |
Why?
| Proto-Oncogene Proteins p21(ras) | 1 | 2021 | 259 | 0.160 |
Why?
| Minor Lymphocyte Stimulatory Antigens | 11 | 1993 | 22 | 0.160 |
Why?
| Sarcoidosis, Pulmonary | 1 | 2020 | 83 | 0.160 |
Why?
| Lipocalins | 1 | 2019 | 36 | 0.160 |
Why?
| Cell Separation | 13 | 2014 | 316 | 0.160 |
Why?
| DNA Mutational Analysis | 2 | 2009 | 387 | 0.160 |
Why?
| Cell Line, Transformed | 2 | 2018 | 141 | 0.160 |
Why?
| Methyltransferases | 1 | 2020 | 70 | 0.160 |
Why?
| Mice, Inbred DBA | 20 | 2002 | 188 | 0.160 |
Why?
| Disease Models, Animal | 7 | 2015 | 4063 | 0.160 |
Why?
| Vaccines | 3 | 2016 | 398 | 0.160 |
Why?
| Lymph Nodes | 12 | 2013 | 472 | 0.160 |
Why?
| Interleukin-4 | 6 | 2008 | 212 | 0.160 |
Why?
| Protein Structure, Secondary | 5 | 2012 | 341 | 0.150 |
Why?
| HIV Envelope Protein gp120 | 1 | 1999 | 57 | 0.150 |
Why?
| T-Lymphocytes, Regulatory | 4 | 2014 | 375 | 0.150 |
Why?
| Molecular Weight | 12 | 2006 | 332 | 0.150 |
Why?
| Genetic Linkage | 8 | 2002 | 299 | 0.150 |
Why?
| Antibody Specificity | 11 | 2020 | 184 | 0.150 |
Why?
| Induced Pluripotent Stem Cells | 1 | 2021 | 221 | 0.150 |
Why?
| Mice, Mutant Strains | 8 | 2014 | 298 | 0.150 |
Why?
| Cell Division | 12 | 2008 | 797 | 0.150 |
Why?
| Species Specificity | 12 | 2006 | 575 | 0.150 |
Why?
| Genome | 2 | 2000 | 278 | 0.150 |
Why?
| Th2 Cells | 3 | 2010 | 171 | 0.150 |
Why?
| Cell Line, Tumor | 6 | 2021 | 3215 | 0.150 |
Why?
| Transcription Factors | 5 | 2024 | 1651 | 0.150 |
Why?
| Hybrid Cells | 4 | 1997 | 50 | 0.150 |
Why?
| Antigens, Ly | 4 | 1988 | 44 | 0.150 |
Why?
| Gene Expression Profiling | 5 | 2013 | 1706 | 0.140 |
Why?
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 1998 | 100 | 0.140 |
Why?
| bcl-X Protein | 4 | 2006 | 42 | 0.140 |
Why?
| Vaccination | 8 | 2010 | 1348 | 0.140 |
Why?
| Hemocyanins | 9 | 1983 | 62 | 0.140 |
Why?
| Herpesviridae | 1 | 2017 | 22 | 0.140 |
Why?
| Erythrocytes | 25 | 2002 | 672 | 0.140 |
Why?
| Interleukin-7 | 4 | 2004 | 59 | 0.140 |
Why?
| Cat Diseases | 1 | 2017 | 19 | 0.140 |
Why?
| Fluorescent Antibody Technique | 6 | 2011 | 376 | 0.130 |
Why?
| Spodoptera | 3 | 2021 | 37 | 0.130 |
Why?
| Solubility | 5 | 2003 | 235 | 0.130 |
Why?
| Cell Communication | 8 | 2013 | 301 | 0.130 |
Why?
| Germ-Line Mutation | 2 | 2009 | 140 | 0.130 |
Why?
| Friend murine leukemia virus | 1 | 2016 | 29 | 0.130 |
Why?
| Deoxyribonucleases | 1 | 2016 | 23 | 0.130 |
Why?
| Antibody-Producing Cells | 11 | 1983 | 30 | 0.130 |
Why?
| Allergens | 1 | 2019 | 385 | 0.130 |
Why?
| Ubiquitin-Protein Ligases | 2 | 2008 | 153 | 0.130 |
Why?
| Antibody Affinity | 4 | 2020 | 59 | 0.130 |
Why?
| Mice, Inbred AKR | 10 | 1989 | 35 | 0.130 |
Why?
| Immunologic Deficiency Syndromes | 3 | 2007 | 63 | 0.130 |
Why?
| Immunity | 3 | 2007 | 139 | 0.130 |
Why?
| Thymocytes | 2 | 2013 | 33 | 0.130 |
Why?
| Protein Precursors | 1 | 2016 | 127 | 0.130 |
Why?
| Clonal Anergy | 3 | 2006 | 51 | 0.130 |
Why?
| Binding, Competitive | 9 | 2010 | 206 | 0.130 |
Why?
| Genetic Predisposition to Disease | 6 | 2021 | 2282 | 0.130 |
Why?
| Hematopoietic Stem Cells | 3 | 1988 | 381 | 0.120 |
Why?
| Methylation | 5 | 2018 | 230 | 0.120 |
Why?
| Mast Cells | 2 | 2009 | 142 | 0.120 |
Why?
| RNA, Messenger | 11 | 2022 | 2708 | 0.120 |
Why?
| Cytotoxicity, Immunologic | 8 | 2010 | 220 | 0.120 |
Why?
| History, 20th Century | 4 | 2016 | 291 | 0.120 |
Why?
| Influenza A virus | 2 | 2013 | 100 | 0.120 |
Why?
| Reactive Oxygen Species | 3 | 2003 | 596 | 0.120 |
Why?
| Cerebroside-Sulfatase | 2 | 1993 | 3 | 0.120 |
Why?
| Leukodystrophy, Metachromatic | 2 | 1993 | 3 | 0.120 |
Why?
| T-Lymphocytes, Cytotoxic | 4 | 2011 | 169 | 0.120 |
Why?
| Breast Neoplasms | 2 | 2018 | 2142 | 0.120 |
Why?
| Polymerase Chain Reaction | 7 | 2016 | 1038 | 0.120 |
Why?
| Self Tolerance | 2 | 1996 | 27 | 0.120 |
Why?
| Interleukin-15 | 5 | 2006 | 82 | 0.110 |
Why?
| Tumor Necrosis Factor-alpha | 6 | 2006 | 1198 | 0.110 |
Why?
| Peptide Biosynthesis | 1 | 1994 | 13 | 0.110 |
Why?
| Ribosomal Proteins | 1 | 2014 | 77 | 0.110 |
Why?
| Mutagenesis, Site-Directed | 3 | 2011 | 361 | 0.110 |
Why?
| Receptors, Immunologic | 3 | 2020 | 216 | 0.110 |
Why?
| Cysteine | 2 | 2010 | 195 | 0.110 |
Why?
| Mutagenesis | 3 | 2021 | 181 | 0.110 |
Why?
| Antigens, CD | 5 | 2001 | 489 | 0.110 |
Why?
| Granuloma | 1 | 2014 | 89 | 0.110 |
Why?
| Haplotypes | 4 | 1990 | 475 | 0.110 |
Why?
| gamma-Globulins | 4 | 1983 | 18 | 0.110 |
Why?
| Immunity, Innate | 4 | 2021 | 804 | 0.110 |
Why?
| Clonal Deletion | 4 | 2004 | 16 | 0.110 |
Why?
| Sodium | 1 | 2014 | 206 | 0.100 |
Why?
| Nucleoproteins | 1 | 2013 | 28 | 0.100 |
Why?
| Viral Proteins | 2 | 2009 | 328 | 0.100 |
Why?
| Hydrogen Bonding | 2 | 2008 | 149 | 0.100 |
Why?
| Gammaherpesvirinae | 1 | 2013 | 45 | 0.100 |
Why?
| Chimera | 8 | 2009 | 59 | 0.100 |
Why?
| HLA Antigens | 4 | 2018 | 234 | 0.100 |
Why?
| Diabetes Mellitus | 1 | 2021 | 1001 | 0.100 |
Why?
| Antigen-Antibody Reactions | 7 | 2021 | 52 | 0.100 |
Why?
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2012 | 26 | 0.100 |
Why?
| Interleukin-2 Receptor alpha Subunit | 1 | 2013 | 82 | 0.100 |
Why?
| Escherichia coli | 4 | 2013 | 774 | 0.100 |
Why?
| Genes, Immunoglobulin | 3 | 1988 | 28 | 0.100 |
Why?
| CD4 Antigens | 9 | 1998 | 138 | 0.100 |
Why?
| Lymphocyte Depletion | 5 | 2001 | 131 | 0.100 |
Why?
| Multiprotein Complexes | 1 | 2014 | 155 | 0.100 |
Why?
| Models, Immunological | 4 | 2008 | 95 | 0.100 |
Why?
| Chromosome Mapping | 8 | 2002 | 504 | 0.100 |
Why?
| B7-1 Antigen | 3 | 2004 | 61 | 0.100 |
Why?
| Chromosomal Proteins, Non-Histone | 1 | 2012 | 116 | 0.100 |
Why?
| Antigens, Differentiation, B-Lymphocyte | 3 | 2013 | 37 | 0.100 |
Why?
| Intestinal Mucosa | 1 | 1997 | 590 | 0.100 |
Why?
| Communicable Diseases | 1 | 1994 | 147 | 0.090 |
Why?
| Dermatitis, Allergic Contact | 1 | 2012 | 70 | 0.090 |
Why?
| Dose-Response Relationship, Immunologic | 12 | 2000 | 82 | 0.090 |
Why?
| Amino Acid Substitution | 3 | 2021 | 282 | 0.090 |
Why?
| Phagocytosis | 2 | 2011 | 362 | 0.090 |
Why?
| Sheep | 20 | 1983 | 837 | 0.090 |
Why?
| Antilymphocyte Serum | 9 | 1981 | 63 | 0.090 |
Why?
| Receptors, CXCR5 | 1 | 2011 | 20 | 0.090 |
Why?
| Lipid A | 1 | 2011 | 29 | 0.090 |
Why?
| Glycosylation | 4 | 1994 | 150 | 0.090 |
Why?
| Molecular Conformation | 2 | 2009 | 144 | 0.090 |
Why?
| Th1 Cells | 2 | 2010 | 138 | 0.090 |
Why?
| Trypsin | 5 | 2006 | 74 | 0.090 |
Why?
| Aluminum | 1 | 2010 | 38 | 0.090 |
Why?
| Tumor Necrosis Factor Ligand Superfamily Member 15 | 1 | 2010 | 8 | 0.090 |
Why?
| Neoplasm Proteins | 1 | 2013 | 424 | 0.090 |
Why?
| DNA, Recombinant | 4 | 2005 | 46 | 0.090 |
Why?
| Gene Deletion | 2 | 2009 | 379 | 0.090 |
Why?
| Lymphocyte Count | 4 | 2010 | 148 | 0.090 |
Why?
| Crosses, Genetic | 7 | 2006 | 142 | 0.090 |
Why?
| Immunization | 8 | 2004 | 411 | 0.090 |
Why?
| Complement C3 | 1 | 2011 | 203 | 0.080 |
Why?
| Insulin-Secreting Cells | 2 | 2016 | 367 | 0.080 |
Why?
| Epstein-Barr Virus Nuclear Antigens | 1 | 2009 | 10 | 0.080 |
Why?
| DNA-Binding Proteins | 3 | 2014 | 1443 | 0.080 |
Why?
| Male | 29 | 2021 | 63681 | 0.080 |
Why?
| Molecular Mimicry | 1 | 2009 | 38 | 0.080 |
Why?
| Chickens | 9 | 1994 | 188 | 0.080 |
Why?
| Radiation Chimera | 6 | 2001 | 29 | 0.080 |
Why?
| Chronic Disease | 5 | 2021 | 1720 | 0.080 |
Why?
| In Vitro Techniques | 8 | 2000 | 1085 | 0.080 |
Why?
| Leukemia, Lymphoid | 3 | 2006 | 27 | 0.080 |
Why?
| bcl-2 Homologous Antagonist-Killer Protein | 2 | 2006 | 15 | 0.080 |
Why?
| Histidine | 2 | 2003 | 60 | 0.080 |
Why?
| Molecular Docking Simulation | 2 | 2021 | 109 | 0.080 |
Why?
| Chromosomes, Human, X | 1 | 2010 | 72 | 0.080 |
Why?
| Immunoglobulin Heavy Chains | 6 | 1988 | 80 | 0.080 |
Why?
| HLA-B Antigens | 1 | 2009 | 62 | 0.080 |
Why?
| Time Factors | 12 | 2013 | 6556 | 0.080 |
Why?
| Cell Membrane | 6 | 2004 | 732 | 0.080 |
Why?
| Antibodies, Neutralizing | 2 | 2022 | 265 | 0.080 |
Why?
| RNA | 4 | 2010 | 883 | 0.080 |
Why?
| Macrophages, Peritoneal | 1 | 2009 | 91 | 0.080 |
Why?
| Sequence Alignment | 2 | 2008 | 332 | 0.080 |
Why?
| Immunity, Humoral | 2 | 2022 | 118 | 0.080 |
Why?
| Mice, Inbred C3H | 7 | 1993 | 273 | 0.080 |
Why?
| Receptors, Interleukin-2 | 4 | 2003 | 66 | 0.080 |
Why?
| Hydrogen-Ion Concentration | 3 | 2003 | 544 | 0.080 |
Why?
| Oligopeptides | 2 | 2001 | 257 | 0.080 |
Why?
| Fluorescent Dyes | 2 | 2001 | 317 | 0.080 |
Why?
| Homeodomain Proteins | 1 | 2012 | 495 | 0.080 |
Why?
| Proto-Oncogene Proteins c-cbl | 1 | 2008 | 11 | 0.080 |
Why?
| Gonadal Steroid Hormones | 1 | 2010 | 131 | 0.080 |
Why?
| DNA (Cytosine-5-)-Methyltransferases | 1 | 1988 | 32 | 0.070 |
Why?
| Chondroitin | 1 | 1988 | 5 | 0.070 |
Why?
| Lymphocytes | 6 | 1997 | 377 | 0.070 |
Why?
| Interleukin-6 | 3 | 2011 | 720 | 0.070 |
Why?
| Ubiquitination | 1 | 2008 | 98 | 0.070 |
Why?
| Protein Domains | 2 | 2020 | 253 | 0.070 |
Why?
| Mass Spectrometry | 3 | 2020 | 716 | 0.070 |
Why?
| Mice, Inbred CBA | 8 | 2001 | 52 | 0.070 |
Why?
| Receptors, Chemokine | 1 | 2008 | 45 | 0.070 |
Why?
| Herpesvirus 4, Human | 1 | 2009 | 153 | 0.070 |
Why?
| Receptors, Tumor Necrosis Factor | 3 | 2003 | 161 | 0.070 |
Why?
| Chondroitin Sulfates | 1 | 1988 | 35 | 0.070 |
Why?
| Interferon-beta | 2 | 2006 | 89 | 0.070 |
Why?
| Protein Structure, Quaternary | 1 | 2008 | 122 | 0.070 |
Why?
| Heterozygote | 2 | 2024 | 272 | 0.070 |
Why?
| Cell Movement | 5 | 2013 | 945 | 0.070 |
Why?
| Galactosylceramides | 1 | 2007 | 23 | 0.070 |
Why?
| Oxidoreductases, N-Demethylating | 1 | 2007 | 16 | 0.070 |
Why?
| Antigens, CD1d | 3 | 2013 | 66 | 0.070 |
Why?
| Blotting, Western | 3 | 2020 | 1205 | 0.070 |
Why?
| Phenotype | 10 | 2008 | 3076 | 0.070 |
Why?
| Gene Rearrangement, T-Lymphocyte | 2 | 2001 | 15 | 0.070 |
Why?
| Recombinant Fusion Proteins | 5 | 2002 | 643 | 0.070 |
Why?
| Interferon-alpha | 2 | 2006 | 194 | 0.070 |
Why?
| Open Reading Frames | 3 | 1992 | 117 | 0.070 |
Why?
| Bone Marrow Cells | 3 | 2016 | 300 | 0.070 |
Why?
| Sequence Homology, Nucleic Acid | 7 | 1992 | 150 | 0.070 |
Why?
| Killer Cells, Natural | 2 | 2007 | 427 | 0.070 |
Why?
| Protein Biosynthesis | 3 | 1992 | 406 | 0.070 |
Why?
| Poly I-C | 1 | 2006 | 62 | 0.070 |
Why?
| Molecular Structure | 2 | 2003 | 482 | 0.070 |
Why?
| Restriction Mapping | 3 | 1998 | 75 | 0.060 |
Why?
| Inflammation Mediators | 1 | 2009 | 505 | 0.060 |
Why?
| Cell Culture Techniques | 3 | 2009 | 345 | 0.060 |
Why?
| Proteins | 2 | 1982 | 942 | 0.060 |
Why?
| Moths | 3 | 1997 | 39 | 0.060 |
Why?
| Chemotaxis, Leukocyte | 2 | 2003 | 137 | 0.060 |
Why?
| Arginine | 2 | 2018 | 265 | 0.060 |
Why?
| Bone Marrow | 4 | 2009 | 271 | 0.060 |
Why?
| Hyaluronan Receptors | 3 | 2003 | 96 | 0.060 |
Why?
| Promoter Regions, Genetic | 4 | 2020 | 1207 | 0.060 |
Why?
| Jurkat Cells | 2 | 2009 | 134 | 0.060 |
Why?
| Epithelium | 6 | 1997 | 311 | 0.060 |
Why?
| Nitrophenols | 10 | 2004 | 33 | 0.060 |
Why?
| Lipopolysaccharides | 8 | 2002 | 875 | 0.060 |
Why?
| Proteolysis | 2 | 2018 | 166 | 0.060 |
Why?
| Organ Culture Techniques | 6 | 1993 | 154 | 0.060 |
Why?
| Oligonucleotides | 2 | 2004 | 140 | 0.060 |
Why?
| Exons | 2 | 2000 | 342 | 0.060 |
Why?
| Histiocytosis, Non-Langerhans-Cell | 1 | 2004 | 5 | 0.060 |
Why?
| CD4-CD8 Ratio | 2 | 2002 | 22 | 0.060 |
Why?
| Case-Control Studies | 3 | 2020 | 3381 | 0.060 |
Why?
| Mice, Inbred A | 6 | 1984 | 48 | 0.060 |
Why?
| Histocompatibility Antigen H-2D | 4 | 2010 | 21 | 0.060 |
Why?
| Gene Library | 1 | 2004 | 116 | 0.050 |
Why?
| Receptors, Leukotriene B4 | 1 | 2003 | 6 | 0.050 |
Why?
| Phosphorylation | 4 | 2020 | 1713 | 0.050 |
Why?
| Leukotriene B4 | 1 | 2003 | 42 | 0.050 |
Why?
| Intercellular Adhesion Molecule-1 | 1 | 2004 | 135 | 0.050 |
Why?
| CD28 Antigens | 2 | 2008 | 48 | 0.050 |
Why?
| Microtubule-Associated Proteins | 1 | 2005 | 192 | 0.050 |
Why?
| Luminescent Proteins | 2 | 2001 | 175 | 0.050 |
Why?
| Selection, Genetic | 2 | 2019 | 249 | 0.050 |
Why?
| Myeloid Cells | 1 | 2004 | 143 | 0.050 |
Why?
| Genes, bcl-2 | 1 | 2002 | 21 | 0.050 |
Why?
| Receptor-CD3 Complex, Antigen, T-Cell | 1 | 2002 | 9 | 0.050 |
Why?
| NF-kappa B | 2 | 2004 | 653 | 0.050 |
Why?
| Talin | 1 | 2002 | 8 | 0.050 |
Why?
| Chemokine CCL5 | 1 | 2002 | 43 | 0.050 |
Why?
| Immunoblotting | 3 | 2008 | 305 | 0.050 |
Why?
| Clodronic Acid | 1 | 2002 | 12 | 0.050 |
Why?
| Anemia, Hemolytic, Autoimmune | 1 | 2002 | 15 | 0.050 |
Why?
| Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 2002 | 22 | 0.050 |
Why?
| Serum Albumin, Bovine | 6 | 2011 | 63 | 0.050 |
Why?
| Phosphoproteins | 1 | 2005 | 332 | 0.050 |
Why?
| Leukocyte Common Antigens | 1 | 2002 | 82 | 0.050 |
Why?
| Colorectal Neoplasms | 1 | 2010 | 752 | 0.050 |
Why?
| Cell Fusion | 4 | 1989 | 51 | 0.050 |
Why?
| Vaccines, Synthetic | 1 | 2022 | 126 | 0.050 |
Why?
| DNA, Viral | 1 | 2004 | 350 | 0.050 |
Why?
| Egg Proteins | 1 | 2001 | 17 | 0.050 |
Why?
| RNA Processing, Post-Transcriptional | 1 | 2002 | 87 | 0.050 |
Why?
| Protein-Tyrosine Kinases | 2 | 2002 | 432 | 0.050 |
Why?
| Genetic Vectors | 2 | 2001 | 312 | 0.050 |
Why?
| HIV Infections | 1 | 2016 | 2720 | 0.050 |
Why?
| Moloney murine leukemia virus | 1 | 2001 | 13 | 0.050 |
Why?
| Sf9 Cells | 1 | 2021 | 9 | 0.050 |
Why?
| Genotype | 4 | 2015 | 1839 | 0.050 |
Why?
| Transduction, Genetic | 1 | 2001 | 128 | 0.050 |
Why?
| Repetitive Sequences, Nucleic Acid | 2 | 1992 | 111 | 0.050 |
Why?
| Temperature | 2 | 2003 | 636 | 0.040 |
Why?
| Cell Cycle Proteins | 1 | 2005 | 586 | 0.040 |
Why?
| Sequence Analysis, DNA | 1 | 2004 | 779 | 0.040 |
Why?
| Receptors, Fc | 2 | 2020 | 52 | 0.040 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2004 | 399 | 0.040 |
Why?
| Borrelia burgdorferi Group | 1 | 2000 | 9 | 0.040 |
Why?
| Dimerization | 2 | 2001 | 192 | 0.040 |
Why?
| Perissodactyla | 8 | 1981 | 12 | 0.040 |
Why?
| Interleukin-1 | 5 | 1997 | 958 | 0.040 |
Why?
| CD40 Antigens | 1 | 2001 | 88 | 0.040 |
Why?
| Melanoma, Experimental | 1 | 2001 | 108 | 0.040 |
Why?
| Allergy and Immunology | 1 | 2001 | 43 | 0.040 |
Why?
| Adoptive Transfer | 4 | 2004 | 218 | 0.040 |
Why?
| Calcium | 6 | 2004 | 1213 | 0.040 |
Why?
| Models, Animal | 1 | 2002 | 376 | 0.040 |
Why?
| Immunoglobulin E | 2 | 2019 | 329 | 0.040 |
Why?
| Receptors, Virus | 1 | 2021 | 83 | 0.040 |
Why?
| Netrin-1 | 1 | 2000 | 12 | 0.040 |
Why?
| Biotinylation | 1 | 2000 | 29 | 0.040 |
Why?
| Phorbol Esters | 1 | 2000 | 15 | 0.040 |
Why?
| Receptors, Antigen, B-Cell | 1 | 2001 | 126 | 0.040 |
Why?
| Expressed Sequence Tags | 1 | 2000 | 41 | 0.040 |
Why?
| Green Fluorescent Proteins | 3 | 2013 | 385 | 0.040 |
Why?
| Mitochondria | 2 | 2004 | 877 | 0.040 |
Why?
| Haploidy | 1 | 1980 | 24 | 0.040 |
Why?
| Immune Sera | 5 | 1984 | 86 | 0.040 |
Why?
| Hot Temperature | 2 | 2000 | 370 | 0.040 |
Why?
| Calorimetry | 1 | 2000 | 66 | 0.040 |
Why?
| Protein Interaction Domains and Motifs | 1 | 2021 | 139 | 0.040 |
Why?
| GTP Phosphohydrolases | 1 | 2000 | 85 | 0.040 |
Why?
| Glucose Intolerance | 1 | 2021 | 142 | 0.040 |
Why?
| Circular Dichroism | 1 | 2000 | 148 | 0.040 |
Why?
| Diet, High-Fat | 1 | 2021 | 239 | 0.040 |
Why?
| B-Cell Activating Factor | 3 | 2006 | 21 | 0.040 |
Why?
| Cytoskeletal Proteins | 1 | 2000 | 146 | 0.040 |
Why?
| Lymphocytic choriomeningitis virus | 2 | 2011 | 24 | 0.040 |
Why?
| Protein Conformation, beta-Strand | 1 | 2019 | 15 | 0.040 |
Why?
| Transcription Factor AP-1 | 1 | 2000 | 85 | 0.040 |
Why?
| Receptors, Complement 3d | 1 | 2020 | 140 | 0.040 |
Why?
| Biological Transport | 2 | 1999 | 401 | 0.040 |
Why?
| Homozygote | 2 | 1991 | 193 | 0.040 |
Why?
| Lipoproteins | 1 | 2000 | 171 | 0.040 |
Why?
| Horses | 8 | 1981 | 107 | 0.040 |
Why?
| Gene Knockout Techniques | 1 | 2020 | 109 | 0.040 |
Why?
| Retroviridae | 2 | 2013 | 99 | 0.040 |
Why?
| Vaccinia | 1 | 1999 | 21 | 0.040 |
Why?
| MAP Kinase Kinase Kinases | 1 | 1999 | 71 | 0.040 |
Why?
| Fibroblasts | 4 | 2017 | 948 | 0.040 |
Why?
| Mice, Nude | 3 | 2013 | 683 | 0.040 |
Why?
| Immunization, Secondary | 1 | 1999 | 87 | 0.040 |
Why?
| Plasmids | 4 | 2001 | 358 | 0.040 |
Why?
| Binding Sites, Antibody | 6 | 1991 | 42 | 0.040 |
Why?
| Computer Simulation | 1 | 2003 | 943 | 0.040 |
Why?
| Sequence Analysis, RNA | 1 | 2021 | 429 | 0.040 |
Why?
| DNA Repair | 1 | 2020 | 207 | 0.040 |
Why?
| fas Receptor | 4 | 2002 | 95 | 0.040 |
Why?
| Recombination, Genetic | 4 | 1988 | 190 | 0.040 |
Why?
| Trinitrobenzenes | 5 | 1982 | 14 | 0.040 |
Why?
| Cell Cycle | 2 | 2020 | 592 | 0.040 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2006 | 958 | 0.040 |
Why?
| Nucleosomes | 1 | 2020 | 137 | 0.040 |
Why?
| Rabbits | 6 | 1984 | 778 | 0.040 |
Why?
| Precipitin Tests | 3 | 2001 | 94 | 0.040 |
Why?
| Trans-Activators | 2 | 2000 | 388 | 0.040 |
Why?
| Coculture Techniques | 2 | 2013 | 226 | 0.040 |
Why?
| Heparin | 1 | 2000 | 253 | 0.040 |
Why?
| Alternative Splicing | 1 | 2000 | 218 | 0.040 |
Why?
| Dogs | 1 | 2019 | 381 | 0.040 |
Why?
| Intercellular Signaling Peptides and Proteins | 2 | 2013 | 375 | 0.040 |
Why?
| Cartilage | 1 | 2000 | 180 | 0.040 |
Why?
| Hemoglobins | 2 | 2001 | 339 | 0.040 |
Why?
| Asparagine | 1 | 1998 | 30 | 0.040 |
Why?
| Crystallography | 2 | 2007 | 26 | 0.040 |
Why?
| Interferon Type I | 1 | 1999 | 139 | 0.040 |
Why?
| Codon | 1 | 1998 | 86 | 0.040 |
Why?
| Receptors, Interferon | 2 | 2013 | 50 | 0.040 |
Why?
| Lupus Nephritis | 2 | 2006 | 49 | 0.040 |
Why?
| Immunoglobulin Fc Fragments | 1 | 1978 | 39 | 0.040 |
Why?
| Tumor Suppressor Proteins | 1 | 2000 | 317 | 0.040 |
Why?
| Cricetinae | 3 | 1994 | 277 | 0.040 |
Why?
| Host-Pathogen Interactions | 1 | 2021 | 352 | 0.040 |
Why?
| MAP Kinase Signaling System | 1 | 1999 | 312 | 0.030 |
Why?
| Immunoprecipitation | 2 | 2008 | 157 | 0.030 |
Why?
| Collagen | 1 | 2000 | 434 | 0.030 |
Why?
| Caspases | 2 | 2014 | 245 | 0.030 |
Why?
| Immunoglobulin Constant Regions | 3 | 1986 | 7 | 0.030 |
Why?
| Societies, Medical | 1 | 2001 | 751 | 0.030 |
Why?
| Age Factors | 4 | 2017 | 3144 | 0.030 |
Why?
| Phylogeny | 1 | 2021 | 852 | 0.030 |
Why?
| Young Adult | 3 | 2020 | 12426 | 0.030 |
Why?
| Epithelial Cells | 2 | 2021 | 1065 | 0.030 |
Why?
| Receptors, IgE | 1 | 1997 | 44 | 0.030 |
Why?
| Cats | 1 | 2017 | 208 | 0.030 |
Why?
| Virus Diseases | 2 | 1992 | 211 | 0.030 |
Why?
| Germinal Center | 1 | 2017 | 57 | 0.030 |
Why?
| Repressor Proteins | 1 | 2000 | 406 | 0.030 |
Why?
| Respiratory Hypersensitivity | 1 | 1997 | 64 | 0.030 |
Why?
| Columbidae | 2 | 1994 | 30 | 0.030 |
Why?
| Chromatography, Gel | 3 | 2014 | 127 | 0.030 |
Why?
| Middle Aged | 5 | 2020 | 31154 | 0.030 |
Why?
| High-Throughput Screening Assays | 1 | 2018 | 138 | 0.030 |
Why?
| Drug Contamination | 1 | 2016 | 51 | 0.030 |
Why?
| Emulsions | 1 | 2016 | 51 | 0.030 |
Why?
| Myeloid Differentiation Factor 88 | 1 | 2016 | 96 | 0.030 |
Why?
| HSP70 Heat-Shock Proteins | 1 | 1996 | 69 | 0.030 |
Why?
| Adult | 6 | 2020 | 35576 | 0.030 |
Why?
| C-Peptide | 1 | 2016 | 163 | 0.030 |
Why?
| Immunoconjugates | 1 | 1997 | 103 | 0.030 |
Why?
| Hematopoiesis | 1 | 1997 | 183 | 0.030 |
Why?
| Fetus | 3 | 1993 | 773 | 0.030 |
Why?
| Chemokine CCL19 | 1 | 2015 | 6 | 0.030 |
Why?
| Chemokine CCL21 | 1 | 2015 | 14 | 0.030 |
Why?
| Imidazoles | 1 | 2016 | 234 | 0.030 |
Why?
| Receptors, CCR7 | 1 | 2015 | 27 | 0.030 |
Why?
| Immunoglobulin Isotypes | 2 | 2008 | 34 | 0.030 |
Why?
| Down-Regulation | 3 | 2003 | 636 | 0.030 |
Why?
| Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 2 | 2012 | 21 | 0.030 |
Why?
| Static Electricity | 1 | 2015 | 116 | 0.030 |
Why?
| Tumor Cells, Cultured | 4 | 2001 | 940 | 0.030 |
Why?
| Genes, T-Cell Receptor beta | 1 | 2014 | 21 | 0.030 |
Why?
| Antibody Diversity | 3 | 1989 | 16 | 0.030 |
Why?
| Databases, Factual | 1 | 2000 | 1269 | 0.030 |
Why?
| V(D)J Recombination | 1 | 2014 | 8 | 0.030 |
Why?
| Immunophenotyping | 3 | 2004 | 311 | 0.030 |
Why?
| Aged | 3 | 2020 | 22103 | 0.030 |
Why?
| Enzyme-Linked Immunospot Assay | 1 | 2014 | 36 | 0.030 |
Why?
| Biological Transport, Active | 1 | 1994 | 78 | 0.030 |
Why?
| Cattle | 4 | 2011 | 976 | 0.030 |
Why?
| Glutamic Acid | 2 | 2010 | 237 | 0.030 |
Why?
| Chromatography, Ion Exchange | 1 | 2014 | 52 | 0.030 |
Why?
| Early Growth Response Protein 2 | 1 | 2013 | 10 | 0.030 |
Why?
| Culture Techniques | 2 | 1973 | 80 | 0.030 |
Why?
| Lymphocyte Function-Associated Antigen-1 | 5 | 1999 | 30 | 0.030 |
Why?
| Enzyme Activation | 3 | 2001 | 811 | 0.030 |
Why?
| Endopeptidases | 1 | 1994 | 87 | 0.030 |
Why?
| Golgi Apparatus | 1 | 1994 | 100 | 0.030 |
Why?
| Receptors, Interleukin-7 | 2 | 2006 | 27 | 0.030 |
Why?
| Forkhead Transcription Factors | 1 | 2014 | 185 | 0.030 |
Why?
| Genetic Carrier Screening | 1 | 1993 | 26 | 0.030 |
Why?
| Kidney | 2 | 2017 | 1385 | 0.030 |
Why?
| Viral Envelope Proteins | 1 | 1994 | 81 | 0.030 |
Why?
| Heparin-binding EGF-like Growth Factor | 1 | 2013 | 15 | 0.030 |
Why?
| Thymectomy | 5 | 1975 | 15 | 0.030 |
Why?
| Endopeptidase K | 1 | 2013 | 15 | 0.030 |
Why?
| Dose-Response Relationship, Drug | 3 | 2003 | 2012 | 0.030 |
Why?
| Growth Substances | 2 | 1983 | 152 | 0.030 |
Why?
| Antibodies, Viral | 1 | 2017 | 601 | 0.030 |
Why?
| Adaptive Immunity | 1 | 2014 | 161 | 0.030 |
Why?
| HLA-DR Serological Subtypes | 1 | 2012 | 4 | 0.030 |
Why?
| Interleukin-10 | 1 | 2015 | 304 | 0.030 |
Why?
| Statistics, Nonparametric | 1 | 2014 | 422 | 0.030 |
Why?
| Diphtheria Toxin | 1 | 2013 | 64 | 0.030 |
Why?
| Epigenesis, Genetic | 1 | 2017 | 613 | 0.030 |
Why?
| Minor Histocompatibility Antigens | 1 | 2013 | 46 | 0.030 |
Why?
| Vomiting | 1 | 1993 | 128 | 0.030 |
Why?
| Genes, MHC Class I | 2 | 2009 | 34 | 0.020 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 331 | 0.020 |
Why?
| Dinoprostone | 2 | 1991 | 186 | 0.020 |
Why?
| DNA Primers | 1 | 2013 | 510 | 0.020 |
Why?
| Microsomes | 1 | 1992 | 35 | 0.020 |
Why?
| Adolescent | 4 | 2016 | 20393 | 0.020 |
Why?
| Zinc | 1 | 1995 | 294 | 0.020 |
Why?
| DNA Restriction Enzymes | 3 | 1986 | 53 | 0.020 |
Why?
| Phosphotyrosine | 2 | 2002 | 36 | 0.020 |
Why?
| Immunoassay | 2 | 1989 | 107 | 0.020 |
Why?
| Child | 4 | 2016 | 20883 | 0.020 |
Why?
| Vinblastine | 3 | 1976 | 69 | 0.020 |
Why?
| Nucleocapsid Proteins | 1 | 2011 | 25 | 0.020 |
Why?
| Viral Core Proteins | 1 | 2011 | 21 | 0.020 |
Why?
| Vaccinia virus | 2 | 2001 | 42 | 0.020 |
Why?
| Methionine | 1 | 1992 | 158 | 0.020 |
Why?
| Cellular Senescence | 1 | 1993 | 181 | 0.020 |
Why?
| Resting Phase, Cell Cycle | 1 | 2011 | 15 | 0.020 |
Why?
| Receptors, Lymphocyte Homing | 1 | 2011 | 16 | 0.020 |
Why?
| Analysis of Variance | 1 | 2014 | 1288 | 0.020 |
Why?
| Mice, Inbred NZB | 2 | 2007 | 16 | 0.020 |
Why?
| Cell Adhesion | 3 | 1999 | 452 | 0.020 |
Why?
| Proteomics | 1 | 2018 | 1062 | 0.020 |
Why?
| Carbohydrates | 1 | 1991 | 64 | 0.020 |
Why?
| Rosette Formation | 2 | 1980 | 16 | 0.020 |
Why?
| Rats | 5 | 2000 | 5500 | 0.020 |
Why?
| Bone Marrow Transplantation | 2 | 1992 | 274 | 0.020 |
Why?
| Salts | 1 | 2010 | 37 | 0.020 |
Why?
| Orthomyxoviridae Infections | 1 | 2011 | 67 | 0.020 |
Why?
| Minor Histocompatibility Loci | 1 | 1990 | 4 | 0.020 |
Why?
| Mutant Chimeric Proteins | 1 | 2010 | 4 | 0.020 |
Why?
| DNA, Bacterial | 1 | 1992 | 324 | 0.020 |
Why?
| RNA, Double-Stranded | 1 | 2010 | 47 | 0.020 |
Why?
| Depression, Chemical | 1 | 1990 | 22 | 0.020 |
Why?
| Lysine | 1 | 2012 | 286 | 0.020 |
Why?
| Milk | 1 | 1991 | 120 | 0.020 |
Why?
| Electrophoretic Mobility Shift Assay | 1 | 2010 | 83 | 0.020 |
Why?
| HLA-B8 Antigen | 1 | 2009 | 14 | 0.020 |
Why?
| Immunodominant Epitopes | 1 | 2010 | 28 | 0.020 |
Why?
| Epoprostenol | 1 | 1991 | 136 | 0.020 |
Why?
| Fibrin | 1 | 2010 | 70 | 0.020 |
Why?
| Nervous System Diseases | 1 | 1993 | 252 | 0.020 |
Why?
| HLA-A Antigens | 1 | 2010 | 53 | 0.020 |
Why?
| Fibrinogen | 1 | 2010 | 164 | 0.020 |
Why?
| Thrombin | 1 | 2010 | 146 | 0.020 |
Why?
| Antioxidants | 2 | 2003 | 559 | 0.020 |
Why?
| Chromosome Deletion | 4 | 1991 | 104 | 0.020 |
Why?
| Injections, Intraperitoneal | 1 | 2009 | 111 | 0.020 |
Why?
| Colonic Neoplasms | 1 | 2012 | 243 | 0.020 |
Why?
| Lipid Metabolism | 1 | 2013 | 497 | 0.020 |
Why?
| DNA, Single-Stranded | 1 | 2010 | 114 | 0.020 |
Why?
| Immunoglobulin Class Switching | 1 | 2009 | 19 | 0.020 |
Why?
| Immunoglobulin Joining Region | 1 | 1988 | 10 | 0.020 |
Why?
| Deoxyribonuclease HpaII | 1 | 1988 | 2 | 0.020 |
Why?
| Deoxyribonuclease BamHI | 1 | 1988 | 3 | 0.020 |
Why?
| Programmed Cell Death 1 Receptor | 1 | 2011 | 232 | 0.020 |
Why?
| Disulfides | 3 | 2003 | 97 | 0.020 |
Why?
| Deoxyribonucleases, Type II Site-Specific | 1 | 1988 | 15 | 0.020 |
Why?
| Caspase 1 | 1 | 2009 | 143 | 0.020 |
Why?
| Goats | 3 | 1973 | 26 | 0.020 |
Why?
| Nedd4 Ubiquitin Protein Ligases | 1 | 2008 | 15 | 0.020 |
Why?
| Phosphorylcholine | 1 | 1988 | 18 | 0.020 |
Why?
| Aged, 80 and over | 1 | 2020 | 7086 | 0.020 |
Why?
| Cell Nucleus | 2 | 1985 | 582 | 0.020 |
Why?
| Integrin alpha4 | 1 | 2008 | 7 | 0.020 |
Why?
| Cell Adhesion Molecules | 1 | 1990 | 173 | 0.020 |
Why?
| Lymphocytic Choriomeningitis | 1 | 2008 | 14 | 0.020 |
Why?
| Transplantation Chimera | 1 | 2008 | 54 | 0.020 |
Why?
| Endosomal Sorting Complexes Required for Transport | 1 | 2008 | 35 | 0.020 |
Why?
| Genes, Switch | 1 | 1988 | 6 | 0.020 |
Why?
| Genetic Engineering | 1 | 2009 | 88 | 0.020 |
Why?
| Eosinophils | 2 | 2004 | 324 | 0.020 |
Why?
| Antigens, Helminth | 1 | 2008 | 12 | 0.020 |
Why?
| Genes, Regulator | 1 | 1988 | 34 | 0.020 |
Why?
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2009 | 149 | 0.020 |
Why?
| Shock, Septic | 1 | 1990 | 209 | 0.020 |
Why?
| Schistosoma mansoni | 1 | 2008 | 37 | 0.020 |
Why?
| Cross-Priming | 1 | 2008 | 18 | 0.020 |
Why?
| Influenza Vaccines | 1 | 2013 | 532 | 0.020 |
Why?
| Biosensing Techniques | 1 | 2009 | 120 | 0.020 |
Why?
| Mannose | 1 | 1987 | 25 | 0.020 |
Why?
| Hexosaminidases | 1 | 1987 | 18 | 0.020 |
Why?
| Infection Control | 1 | 2009 | 140 | 0.020 |
Why?
| Introns | 1 | 1988 | 251 | 0.020 |
Why?
| Nitrobenzenes | 3 | 1976 | 13 | 0.020 |
Why?
| RNA-Binding Proteins | 1 | 2011 | 388 | 0.020 |
Why?
| Yersinia enterocolitica | 1 | 2007 | 7 | 0.020 |
Why?
| Antigens, CD1 | 1 | 2007 | 58 | 0.020 |
Why?
| Leukemia P388 | 2 | 1984 | 7 | 0.020 |
Why?
| Fluoresceins | 2 | 2004 | 48 | 0.020 |
Why?
| Oligosaccharides | 1 | 1987 | 57 | 0.020 |
Why?
| Genetic Variation | 2 | 1990 | 937 | 0.020 |
Why?
| Hypersensitivity, Delayed | 3 | 1978 | 28 | 0.020 |
Why?
| Nucleic Acid Conformation | 1 | 2010 | 706 | 0.020 |
Why?
| Pepsin A | 1 | 1986 | 19 | 0.020 |
Why?
| Proto-Oncogene Proteins c-jun | 1 | 2006 | 52 | 0.020 |
Why?
| Weight Loss | 1 | 1992 | 734 | 0.020 |
Why?
| Immunologic Techniques | 2 | 1983 | 39 | 0.020 |
Why?
| Health | 1 | 2007 | 74 | 0.020 |
Why?
| Antibodies, Antinuclear | 1 | 2006 | 66 | 0.020 |
Why?
| Oligonucleotides, Antisense | 2 | 2000 | 113 | 0.020 |
Why?
| Lymphoma | 5 | 1985 | 196 | 0.020 |
Why?
| Half-Life | 2 | 1977 | 162 | 0.020 |
Why?
| Antigens, T-Independent | 2 | 1983 | 4 | 0.020 |
Why?
| Proteinuria | 1 | 2006 | 91 | 0.020 |
Why?
| Transgenes | 2 | 1997 | 177 | 0.020 |
Why?
| Leukopoiesis | 1 | 2006 | 11 | 0.020 |
Why?
| Peptide Hydrolases | 1 | 2006 | 107 | 0.020 |
Why?
| Kidney Glomerulus | 1 | 2006 | 109 | 0.020 |
Why?
| Liposomes | 2 | 2002 | 168 | 0.020 |
Why?
| Body Weight | 1 | 1990 | 940 | 0.020 |
Why?
| Immunoenzyme Techniques | 1 | 1985 | 213 | 0.020 |
Why?
| Guinea Pigs | 2 | 1977 | 157 | 0.020 |
Why?
| Prostaglandins E | 1 | 1985 | 47 | 0.010 |
Why?
| Drug Synergism | 2 | 1983 | 371 | 0.010 |
Why?
| Cytoplasm | 1 | 1985 | 263 | 0.010 |
Why?
| Succinimides | 1 | 2004 | 18 | 0.010 |
Why?
| Protein Denaturation | 1 | 1984 | 75 | 0.010 |
Why?
| Immunoglobulin Allotypes | 1 | 1984 | 9 | 0.010 |
Why?
| Immunoglobulin Light Chains | 1 | 1984 | 40 | 0.010 |
Why?
| Freund's Adjuvant | 1 | 2004 | 18 | 0.010 |
Why?
| Interphase | 2 | 2000 | 31 | 0.010 |
Why?
| Albumins | 1 | 1984 | 103 | 0.010 |
Why?
| DNA, Complementary | 1 | 2004 | 270 | 0.010 |
Why?
| United States | 1 | 2001 | 13903 | 0.010 |
Why?
| B-Cell CLL-Lymphoma 10 Protein | 1 | 2004 | 2 | 0.010 |
Why?
| Genetic Markers | 1 | 1985 | 338 | 0.010 |
Why?
| Immunoglobulins | 1 | 1984 | 159 | 0.010 |
Why?
| Antigens, Differentiation | 2 | 1997 | 81 | 0.010 |
Why?
| Sex Factors | 1 | 2010 | 1968 | 0.010 |
Why?
| Isoelectric Focusing | 1 | 1983 | 34 | 0.010 |
Why?
| Leukemia, Experimental | 1 | 1983 | 27 | 0.010 |
Why?
| Macrophage-Activating Factors | 1 | 1983 | 4 | 0.010 |
Why?
| Hemagglutination Tests | 2 | 1973 | 7 | 0.010 |
Why?
| Catalase | 1 | 2003 | 129 | 0.010 |
Why?
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2004 | 147 | 0.010 |
Why?
| Receptors, CCR5 | 1 | 2003 | 57 | 0.010 |
Why?
| B-Cell Activation Factor Receptor | 1 | 2003 | 13 | 0.010 |
Why?
| Lung Diseases | 1 | 2010 | 742 | 0.010 |
Why?
| Nucleic Acid Hybridization | 2 | 1999 | 189 | 0.010 |
Why?
| Incidence | 1 | 2010 | 2644 | 0.010 |
Why?
| Birds | 1 | 1983 | 83 | 0.010 |
Why?
| Fas Ligand Protein | 1 | 2003 | 58 | 0.010 |
Why?
| Karyotyping | 1 | 1983 | 107 | 0.010 |
Why?
| Neuropeptides | 1 | 2003 | 71 | 0.010 |
Why?
| ZAP-70 Protein-Tyrosine Kinase | 1 | 2002 | 10 | 0.010 |
Why?
| Prognosis | 1 | 1991 | 3794 | 0.010 |
Why?
| Lod Score | 1 | 2002 | 66 | 0.010 |
Why?
| Lymphocyte Culture Test, Mixed | 3 | 1990 | 50 | 0.010 |
Why?
| Ubiquitin C | 1 | 2001 | 3 | 0.010 |
Why?
| Graft Rejection | 1 | 1986 | 598 | 0.010 |
Why?
| Drug Evaluation, Preclinical | 1 | 2002 | 171 | 0.010 |
Why?
| Sex Chromosome Aberrations | 1 | 1981 | 63 | 0.010 |
Why?
| Fetal Blood | 1 | 1983 | 316 | 0.010 |
Why?
| CD79 Antigens | 1 | 2001 | 15 | 0.010 |
Why?
| Virus Assembly | 1 | 2002 | 76 | 0.010 |
Why?
| Bacterial Proteins | 1 | 2007 | 835 | 0.010 |
Why?
| Growth Inhibitors | 1 | 2001 | 44 | 0.010 |
Why?
| Myoglobin | 1 | 2000 | 12 | 0.010 |
Why?
| Organ Specificity | 1 | 2001 | 296 | 0.010 |
Why?
| Genes, Reporter | 1 | 2001 | 267 | 0.010 |
Why?
| Neoplasm Transplantation | 1 | 2001 | 257 | 0.010 |
Why?
| Lyme Disease Vaccines | 1 | 2000 | 3 | 0.010 |
Why?
| Sequence Analysis | 1 | 2000 | 37 | 0.010 |
Why?
| Aspartic Acid | 1 | 2001 | 81 | 0.010 |
Why?
| Models, Biological | 2 | 2001 | 1722 | 0.010 |
Why?
| Up-Regulation | 1 | 2003 | 840 | 0.010 |
Why?
| Biopolymers | 1 | 2000 | 33 | 0.010 |
Why?
| Lymphocyte Subsets | 1 | 2000 | 84 | 0.010 |
Why?
| Receptors, Interleukin-15 | 1 | 2000 | 3 | 0.010 |
Why?
| Staining and Labeling | 2 | 1980 | 141 | 0.010 |
Why?
| Suppressor of Cytokine Signaling 1 Protein | 1 | 2000 | 12 | 0.010 |
Why?
| Specific Pathogen-Free Organisms | 1 | 2000 | 60 | 0.010 |
Why?
| Bacterial Vaccines | 1 | 2000 | 62 | 0.010 |
Why?
| Suppressor of Cytokine Signaling Proteins | 1 | 2000 | 21 | 0.010 |
Why?
| Bacterial Outer Membrane Proteins | 1 | 2000 | 58 | 0.010 |
Why?
| HLA-DRB1 Chains | 1 | 2000 | 108 | 0.010 |
Why?
| Receptors, Interleukin-6 | 1 | 2000 | 38 | 0.010 |
Why?
| In Situ Hybridization | 1 | 2000 | 295 | 0.010 |
Why?
| Child, Preschool | 2 | 1993 | 10517 | 0.010 |
Why?
| Septins | 1 | 2000 | 43 | 0.010 |
Why?
| Cell Lineage | 1 | 2001 | 333 | 0.010 |
Why?
| STAT1 Transcription Factor | 1 | 2000 | 70 | 0.010 |
Why?
| MAP Kinase Kinase Kinase 2 | 1 | 1999 | 12 | 0.010 |
Why?
| Lyme Disease | 1 | 2000 | 56 | 0.010 |
Why?
| GTP-Binding Proteins | 1 | 2000 | 157 | 0.010 |
Why?
| Indicators and Reagents | 1 | 2000 | 109 | 0.010 |
Why?
| Genes, Dominant | 1 | 1999 | 92 | 0.010 |
Why?
| Lymphocyte Transfusion | 1 | 1999 | 20 | 0.010 |
Why?
| Leukemia L1210 | 1 | 1999 | 7 | 0.010 |
Why?
| Multigene Family | 2 | 1991 | 199 | 0.010 |
Why?
| Androstadienes | 1 | 1999 | 106 | 0.010 |
Why?
| Lymphopenia | 1 | 1999 | 59 | 0.010 |
Why?
| Tissue Distribution | 2 | 1993 | 315 | 0.010 |
Why?
| Free Radical Scavengers | 1 | 1999 | 83 | 0.010 |
Why?
| JNK Mitogen-Activated Protein Kinases | 1 | 1999 | 161 | 0.010 |
Why?
| Manganese | 1 | 1999 | 61 | 0.010 |
Why?
| Mitogen-Activated Protein Kinase 3 | 1 | 1999 | 151 | 0.010 |
Why?
| Cholic Acids | 1 | 1998 | 17 | 0.010 |
Why?
| Detergents | 1 | 1998 | 44 | 0.010 |
Why?
| Protein Isoforms | 1 | 2000 | 391 | 0.010 |
Why?
| Metalloporphyrins | 1 | 1999 | 101 | 0.010 |
Why?
| Mitogen-Activated Protein Kinase 1 | 1 | 1999 | 184 | 0.010 |
Why?
| Absorption | 2 | 1975 | 58 | 0.010 |
Why?
| p38 Mitogen-Activated Protein Kinases | 1 | 1999 | 274 | 0.010 |
Why?
| Membrane Potentials | 1 | 1999 | 293 | 0.010 |
Why?
| Nuclear Proteins | 1 | 2003 | 663 | 0.010 |
Why?
| STAT3 Transcription Factor | 1 | 2000 | 195 | 0.010 |
Why?
| Polysaccharides, Bacterial | 2 | 1975 | 67 | 0.010 |
Why?
| Mitogen-Activated Protein Kinases | 1 | 1999 | 312 | 0.010 |
Why?
| Histocompatibility | 1 | 1977 | 26 | 0.010 |
Why?
| Microscopy, Fluorescence | 1 | 1999 | 400 | 0.010 |
Why?
| Isoantigens | 1 | 1977 | 13 | 0.010 |
Why?
| Endocytosis | 1 | 1998 | 163 | 0.010 |
Why?
| STAT6 Transcription Factor | 1 | 1997 | 26 | 0.010 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 1999 | 359 | 0.010 |
Why?
| Hybridization, Genetic | 1 | 1978 | 79 | 0.010 |
Why?
| Abatacept | 1 | 1997 | 46 | 0.010 |
Why?
| Autoanalysis | 1 | 1977 | 8 | 0.010 |
Why?
| Trypan Blue | 1 | 1977 | 6 | 0.010 |
Why?
| Infant | 1 | 1991 | 9024 | 0.010 |
Why?
| Interleukins | 1 | 1999 | 241 | 0.010 |
Why?
| Cytotoxicity Tests, Immunologic | 1 | 1977 | 41 | 0.010 |
Why?
| Gene Transfer Techniques | 1 | 1998 | 163 | 0.010 |
Why?
| CTLA-4 Antigen | 1 | 1997 | 87 | 0.010 |
Why?
| Warfarin | 1 | 1978 | 147 | 0.010 |
Why?
| Whole-Body Irradiation | 1 | 1997 | 76 | 0.010 |
Why?
| Genetic Complementation Test | 2 | 1986 | 63 | 0.010 |
Why?
| Antigen-Antibody Complex | 2 | 1987 | 84 | 0.010 |
Why?
| Enzyme Inhibitors | 1 | 1999 | 827 | 0.010 |
Why?
| Immunity, Mucosal | 1 | 1997 | 94 | 0.010 |
Why?
| Sequence Homology | 1 | 1995 | 40 | 0.010 |
Why?
| Radiation Effects | 1 | 1975 | 4 | 0.010 |
Why?
| Mollusca | 1 | 1975 | 6 | 0.010 |
Why?
| Trachea | 1 | 1997 | 220 | 0.010 |
Why?
| Surface Properties | 1 | 1976 | 399 | 0.010 |
Why?
| Skin Tests | 1 | 1975 | 100 | 0.010 |
Why?
| Methods | 1 | 1974 | 64 | 0.010 |
Why?
| Complement System Proteins | 2 | 1974 | 313 | 0.010 |
Why?
| Transferrin | 1 | 1993 | 42 | 0.010 |
Why?
| Hindlimb | 1 | 1974 | 122 | 0.010 |
Why?
| Umbilical Cord | 1 | 1994 | 83 | 0.010 |
Why?
| Transplantation Immunology | 1 | 1993 | 34 | 0.010 |
Why?
| Cell Transplantation | 1 | 1993 | 37 | 0.010 |
Why?
| Viral Plaque Assay | 1 | 1973 | 29 | 0.010 |
Why?
| Animals, Newborn | 2 | 1988 | 835 | 0.010 |
Why?
| Immunoglobulin M | 1 | 1975 | 275 | 0.010 |
Why?
| Bufo marinus | 1 | 1973 | 4 | 0.010 |
Why?
| Antibodies, Anti-Idiotypic | 2 | 1983 | 57 | 0.010 |
Why?
| Blotting, Southern | 1 | 1993 | 69 | 0.010 |
Why?
| Fetal Tissue Transplantation | 1 | 1992 | 35 | 0.010 |
Why?
| Pedigree | 1 | 1994 | 487 | 0.010 |
Why?
| Macaca mulatta | 1 | 1993 | 149 | 0.010 |
Why?
| Embryonic and Fetal Development | 1 | 1992 | 94 | 0.010 |
Why?
| Models, Structural | 1 | 1991 | 39 | 0.010 |
Why?
| Disease | 1 | 1993 | 95 | 0.010 |
Why?
| Liver | 2 | 1992 | 1839 | 0.010 |
Why?
| Ionomycin | 1 | 1991 | 24 | 0.010 |
Why?
| DNA Methylation | 1 | 1996 | 607 | 0.010 |
Why?
| Oligodeoxyribonucleotides | 1 | 1992 | 138 | 0.010 |
Why?
| Tetradecanoylphorbol Acetate | 1 | 1991 | 149 | 0.010 |
Why?
| Erythrocyte Transfusion | 1 | 1973 | 181 | 0.010 |
Why?
| 6-Ketoprostaglandin F1 alpha | 1 | 1991 | 21 | 0.010 |
Why?
| Calcimycin | 1 | 1991 | 49 | 0.010 |
Why?
| Blotting, Northern | 1 | 1991 | 200 | 0.010 |
Why?
| Endothelium, Vascular | 1 | 1997 | 901 | 0.010 |
Why?
| Arthritis | 1 | 1991 | 90 | 0.010 |
Why?
| Immunotherapy, Adoptive | 1 | 1993 | 295 | 0.010 |
Why?
| Receptors, Leukocyte-Adhesion | 1 | 1990 | 5 | 0.010 |
Why?
| Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 1 | 1990 | 8 | 0.010 |
Why?
| Thymidine | 1 | 1970 | 59 | 0.010 |
Why?
| Oligonucleotide Probes | 1 | 1990 | 50 | 0.010 |
Why?
| RNA Splicing | 1 | 1991 | 262 | 0.010 |
Why?
| Amidohydrolases | 1 | 1990 | 30 | 0.010 |
Why?
| Cytosine | 1 | 1970 | 46 | 0.010 |
Why?
| Carbon Isotopes | 1 | 1970 | 126 | 0.000 |
Why?
| Cricetulus | 1 | 1989 | 107 | 0.000 |
Why?
| Reference Values | 1 | 1990 | 793 | 0.000 |
Why?
| Gestational Age | 1 | 1992 | 874 | 0.000 |
Why?
| Extracellular Space | 1 | 1989 | 120 | 0.000 |
Why?
| Cross-Linking Reagents | 1 | 1989 | 205 | 0.000 |
Why?
| Microspheres | 1 | 1988 | 127 | 0.000 |
Why?
| Treatment Outcome | 1 | 2002 | 10230 | 0.000 |
Why?
| Bacteriophage lambda | 1 | 1988 | 88 | 0.000 |
Why?
| Leukocyte Count | 1 | 1988 | 326 | 0.000 |
Why?
| Adrenergic beta-Antagonists | 1 | 1970 | 321 | 0.000 |
Why?
| Enhancer Elements, Genetic | 1 | 1988 | 177 | 0.000 |
Why?
| Glass | 1 | 1986 | 42 | 0.000 |
Why?
| Staphylococcal Infections | 1 | 1990 | 393 | 0.000 |
Why?
| Immunoglobulin J-Chains | 1 | 1985 | 6 | 0.000 |
Why?
| Transformation, Genetic | 1 | 1985 | 15 | 0.000 |
Why?
| Mast-Cell Sarcoma | 1 | 1985 | 6 | 0.000 |
Why?
| Liver Transplantation | 1 | 1992 | 831 | 0.000 |
Why?
| Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase | 1 | 1984 | 1 | 0.000 |
Why?
| Mesylates | 1 | 1984 | 7 | 0.000 |
Why?
| Acetylglucosaminidase | 1 | 1984 | 5 | 0.000 |
Why?
| Sezary Syndrome | 1 | 1984 | 44 | 0.000 |
Why?
| Membranes, Artificial | 1 | 1984 | 70 | 0.000 |
Why?
| Rats, Inbred Strains | 1 | 1984 | 368 | 0.000 |
Why?
| Thymus Neoplasms | 1 | 1984 | 22 | 0.000 |
Why?
| Bacteria | 1 | 1991 | 821 | 0.000 |
Why?
| Isoelectric Point | 1 | 1984 | 23 | 0.000 |
Why?
| Fixatives | 1 | 1983 | 15 | 0.000 |
Why?
| Cell-Free System | 1 | 1983 | 48 | 0.000 |
Why?
| Glutaral | 1 | 1983 | 15 | 0.000 |
Why?
| Receptors, Antigen | 1 | 1983 | 15 | 0.000 |
Why?
| Chemical Precipitation | 1 | 1983 | 37 | 0.000 |
Why?
| Longitudinal Studies | 1 | 1990 | 2717 | 0.000 |
Why?
| Tomography, X-Ray Computed | 1 | 1993 | 2535 | 0.000 |
Why?
| X Chromosome | 1 | 1981 | 52 | 0.000 |
Why?
| Magnetic Resonance Imaging | 1 | 1993 | 3408 | 0.000 |
Why?
| Brain | 1 | 1993 | 2679 | 0.000 |
Why?
| Pulmonary Alveoli | 1 | 1983 | 400 | 0.000 |
Why?
| Pregnancy | 1 | 1992 | 6402 | 0.000 |
Why?
| Polymers | 1 | 1983 | 479 | 0.000 |
Why?
| Sarcoma, Experimental | 1 | 1974 | 7 | 0.000 |
Why?
| Immunoglobulin Fragments | 1 | 1974 | 11 | 0.000 |
Why?
|
|
Kappler's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|